Origin, phenotype and function of human natural killer cells in pregnancy

Trends in Immunology

Volumn 32, Issue 11, 2011, Pages 517-523

  Vacca, Paola ^a   Moretta, Lorenzo ^b   Moretta, Alessandro ^c   Mingari, Maria Cristina ^a,c  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTEGRIN; ALPHA6 INTEGRIN; CD151 ANTIGEN; CD16 ANTIGEN; CD34 ANTIGEN; CD69 ANTIGEN; CD9 ANTIGEN; CD94 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANZYME; HLA ANTIGEN CLASS 1; INTERLEUKIN 10; INTERLEUKIN 8; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; L SELECTIN; PERFORIN; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

ANGIOGENESIS; CELL FUNCTION; CELL INTERACTION; CELL TYPE; CYTOKINE RELEASE; CYTOTOXICITY; DECIDUA; FETOPLACENTAL UNIT; FIRST TRIMESTER PREGNANCY; HISTOINCOMPATIBILITY; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; NATURAL KILLER CELL; NONHUMAN; PLACENTA DEVELOPMENT; PREGNANCY; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE SUBPOPULATION; TROPHOBLAST;

ANTIGENS, CD14; ANTIGENS, CD34; FEMALE; HUMANS; KILLER CELLS, NATURAL; PHENOTYPE; PREGNANCY; T-LYMPHOCYTES, REGULATORY;

EID: 82455210781     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2011.06.013     Document Type: Review

References (106)

1. Bulmer J.N., et al. Immune cells in the placental bed. Int. J. Dev. Biol. 2010, 54:281-294.
2. Bulmer J.N., Johnson P.M. Macrophage populations in the human placenta and amniochorion. Clin. Exp. Immunol. 1984, 57:393-403.
3. Laskarin G., et al. The presence of functional mannose receptor on macrophages at the maternal-fetal interface. Hum. Reprod. 2005, 20:1057-1066.
4. Gustafsson C. Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype. PLoS ONE 2008, 3:e2078.
5. Tafuri A., et al. T cell awareness of paternal alloantigens during pregnancy. Science 1995, 270:630-633.
6. Saito S., et al. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am. J. Reprod. Immunol. 2010, 63:601-610.
7. Hanna J., Mandelboim O. When killers become helpers. Trends Immunol. 2007, 28:201-206.
8. Hanna J., et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 2006, 12:1065-1074.
9. Caligiuri M.A. Human natural killer cells. Blood 2008, 112:461-469.
10. Moretta A., et al. NK cells at the interface between innate and adaptive immunity. Cell Death Differ. 2008, 15:226-233.
11. Sivori S., et al. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:10116-10121.
12. Sivori S., et al. Extending killer Ig-like receptor function: from HLA-class I recognition to sensors of microbial products. Trends Immunol. 2010, 31:289-294.
13. Moretta L., et al. Surface NK receptors and their ligands on tumor cells. Semin. Immunol. 2006, 18:151-158.
14. Bottino C., et al. Cellular ligands of activating NK receptors. Trends Immunol. 2005, 26:221-226.
15. Moretta L., et al. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J. 2004, 23:255-259.
16. Moretta L., et al. Killer immunoglobulin-like receptors. Curr. Opin. Immunol. 2004, 16:626-633.
17. Mingari M.C., et al. p75/AIRM1 and CD33, two sialoadhesin receptors that regulate the proliferation or the survival of normal and leukemic myeloid cells. Immunol. Rev. 2001, 181:260-268.
18. Cantoni C., et al. Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur. J. Immunol. 1999, 29:3148-3159.
19. Moretta L., et al. Effector and regulatory events during natural killer-dendritic cell interactions. Immunol. Rev. 2006, 214:219-228.
20. Romagnani C., et al. CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J. Immunol. 2007, 178:4947-4955.
21. Ferlazzo G., et al. The abundant lymphoid tissues require to express killer cell Ig like receptor and become cytolytic. J. Immunol. 2004, 172:1455-1462.
22. Fauriat C., et al. Regulation of human NK cell cytokine and chemokine production by target cell recognition. Blood 2010, 115:2167-2176.
23. De Maria A., et al. Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:728-732.
24. Juelke K., et al. CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. Blood 2010, 116:1299-1307.
25. Yu J., et al. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Blood 2010, 115:274-281.
26. Björkström N.K., et al. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010, 116:3853-3864.
27. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat. Rev. Immunol. 2002, 2:957-964.
28. Agaugue S., et al. Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells. Blood 2008, 112:1776-1783.
29. King A., et al. CD3- leukocytes present in the human uterus during early placentation: phenotypic and morphologic characterization of the CD56++ population. Dev. Immunol. 1991, 1:169-190.
30. Hamperl H., Hellweg G. Granular endometrial stroma cells. Obstet. Gynecol. 1958, 11:379-387.
31. King A., et al. Immunocytochemical characterization of the unusual large granular lymphocytes in human endometrium throughout the menstrual cycle. Hum. Immunol. 1989, 24:195-205.
32. Moffett-King A. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2002, 2:656-663.
33. Bulmer J.N., Sunderland C.A. Immunohistological characterization of lymphoid cell populations in the early human placental bed. Immunology 1984, 52:349-357.
34. Manaster I., Mandelboim O. The unique properties of human NK cells in the uterine mucosa. Placenta 2008, 29(Suppl A):S60-S66.
35. Jones R.K., et al. Cytotoxic activity of endometrial granulated lymphocytes during the menstrual cycle in humans. Biol. Reprod. 1997, 57:1217-1222.
36. Kopcow H.D., et al. Human decidual NK cells from gravid uteri and NK cells from cycling endometrium are distinct NK cell subsets. Placenta 2010, 31:334-338.
37. Ritson A., Bulmer J.N. Endometrial granulocytes in human decidua react with a natural-killer (NK) cell marker, NKH1. Immunology 1987, 62:329-331.
38. Manaster I., Mandelboim O. The unique properties of uterine NK cells. Am. J. Reprod. Immunol. 2010, 63:434-444.
39. Eriksson M., et al. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta. J. Leukoc. Biol. 2004, 76:667-675.
40. Koopman L.A., et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 2003, 198:1201-1212.
41. Verma S., et al. Expression of killer cell inhibitory receptors on human uterine natural killer cells. Eur. J. Immunol. 1997, 27:979-983.
42. Sharkey A.M., et al. Killer Ig-like receptor expression in uterine NK cells is biased toward recognition of HLA-C and alters with gestational age. J. Immunol. 2008, 181:39-46.
43. Kusumi M., et al. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells. J. Reprod. Immunol. 2006, 70:33-42.
44. Apps R., et al. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur. J. Immunol. 2007, 37:1924-1937.
45. El Costa H., et al. Critical and differential roles of NKp46- and NKp30-activating receptors expressed by uterine NK cells in early pregnancy. J. Immunol. 2008, 181:3009-3017.
46. Kopcow H.D., et al. Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:15563-15568.
47. Vacca P., et al. Analysis of natural killer cells isolated from human decidua: evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function. Blood 2006, 108:4078-4085.
48. Vacca P., et al. Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells. Int. Immunol. 2008, 20:1395-1405.
49. Apps R. Natural-killer cell ligands at the maternal-fetal interface: UL-16 binding proteins, MHC class-I chain related molecules, HLA-F and CD48. Hum. Reprod. 2008, 23:2535-2548.
50. King A., et al. Expression of perforin, granzyme A and TIA-1 by human uterine CD56+ NK cells implies they are activated and capable of effector functions. Hum. Reprod. 1993, 8:2061-2067.
51. Nakashima A., et al. Granulysin produced by uterine natural killer cells induces apoptosis of extravillous trophoblasts in spontaneous abortion. Am. J. Pathol. 2008, 173:653-664.
52. King A., et al. Early human decidual cells exhibit NK activity against the K562 cell line but not against first trimester trophoblast. Cell Immunol. 1989, 118:337-344.
53. Hiby S.E., et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J. Clin. Invest. 2010, 120:4102-4110.
54. Rajagopalan S., et al. Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J. Immunol. 2001, 167:1877-1881.
55. Gonen-Gross T., et al. Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function. J. Immunol. 2003, 171:1343-1351.
56. Ponte M., et al. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:5674-5679.
57. Le Bouteiller P., Tabiasco J. Killers become builders during pregnancy. Nat. Med. 2006, 12:991-992.
58. Bulmer J.N., et al. Immunohistochemical localization of interferons in human placental tissues in normal, ectopic, and molar pregnancy. Am. J. Reprod. Immunol. 1990, 22:109-116.
59. Saito S., et al. Cytokine production by CD16-CD56bright natural killer cells in the human early pregnancy decidua. Int. Immunol. 1993, 5:559-563.
60. Jokhi P.P., et al. Cytokine production and cytokine receptor expression by cells of the human first trimester placental-uterine interface. Cytokine 1997, 9:126-137.
61. Lash G.E., et al. Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J. Leukoc. Biol. 2006, 80:572-580.
62. Moffett A., Loke C. Immunology of placentation in eutherian mammals. Nat. Rev. Immunol. 2006, 6:584-594.
63. Rajagopalan S., Long E.O. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J. Exp. Med. 1999, 189:1093-1100.
64. Apps R., et al. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 2009, 127:26-39.
65. Hiby S.E., et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 2004, 200:957-965.
66. Sivori S., et al. Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines. Hum. Immunol. 2000, 61:1055-1058.
67. Sakaguchi S., et al. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
68. Saito S., et al. Inadequate tolerance induction may induce pre-eclampsia. J. Reprod. Immunol. 2007, 76:30-39.
69. Heikkinen J., et al. Phenotypic characterization of regulatory T cells in the human decidua. Clin. Exp. Immunol. 2004, 136:373-378.
70. Thuere C., et al. Kinetics of regulatory T cells during murine pregnancy. Am. J. Reprod. Immunol. 2007, 58:514-523.
71. Sasaki Y., et al. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol. Hum. Reprod. 2004, 10:347-353.
72. Von Rango U., et al. Indoleamine-dioxygenase is expressed in human decidua at the time maternal tolerance is established. J. Reprod. Immunol. 2007, 74:34-45.
73. Chung D.J., et al. Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells. Blood 2009, 114:555-563.
74. Munn D.H., et al. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 1999, 189:1363-1372.
75. Munn D.H., et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998, 281:1191-1193.
76. Fallarino F., et al. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 2003, 4:1206-1212.
77. Baban B., et al. Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. J. Reprod. Immunol. 2004, 61:67-77.
78. Terness P., et al. Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells. Am. J. Reprod. Immunol. 2007, 58:238-254.
79. Kammerer U., et al. Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. Am. J. Pathol. 2003, 162:887-896.
80. Vacca P., et al. Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11918-11923.
81. Della Chiesa M., et al. The tryptophan catabolite l-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function. Blood 2006, 108:4118-4125.
82. Quack K.C., et al. Leukocyte activation in the decidua of chromosomally normal and abnormal fetuses from women with recurrent abortion. Hum. Reprod. 2001, 16:949-955.
83. Tai P., et al. Induction of regulatory T cells by physiological level estrogen. J. Cell Physiol. 2008, 214:456-464.
84. Zhao J.X., et al. Fetal alloantigen is responsible for the expansion of the CD4(+)CD25(+) regulatory T cell pool during pregnancy. J. Reprod. Immunol. 2007, 75:71-81.
85. Robertson S.A., et al. Seminal fluid drives expansion of the CD4+CD25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol. Reprod. 2009, 80:1036-1045.
86. Zenclussen M.L., et al. The persistence of paternal antigens in the maternal body is involved in regulatory T-cell expansion and fetal-maternal tolerance in murine pregnancy. Am. J. Reprod. Immunol. 2010, 63:200-208.
87. Bulmer J.N., Lash G.E. Human uterine natural killer cells: a reappraisal. Mol. Immunol. 2005, 42:511-521.
88. Keskin D.B., et al. TGFbeta promotes conversion of CD16+ peripheral blood NK cells into CD16- NK cells with similarities to decidual NK cells. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:3378-3383.
89. Carlino C., et al. Recruitment of circulating NK cells through decidual tissues: a possible mechanism controlling NK cell accumulation in the uterus during early pregnancy. Blood 2008, 111:3108-3115.
90. Hanna J., et al. CXCL12 expression by invasive trophoblasts induces the specific migration of CD16- human natural killer cells. Blood 2003, 102:1569-1577.
91. Sentman C.L., et al. Recruitment of uterine NK cells: induction of CXC chemokine ligands 10 and 11 in human endometrium by estradiol and progesterone. J. Immunol. 2004, 173:6760-6766.
92. Wu X., et al. Human first-trimester trophoblast cells recruit CD56brightCD16- NK cells into decidua by way of expressing and secreting of CXCL12/stromal cell-derived factor 1. J. Immunol. 2005, 175:61-68.
93. Hannan N.J., et al. Coexpression of fractalkine and its receptor in normal human endometrium and in endometrium from users of progestin-only contraception supports a role for fractalkine in leukocyte recruitment and endometrial remodeling. J. Clin. Endocrinol. Metab. 2004, 89:6119-6129.
94. Kunkel E.J., Butcher E.C. Chemokines and the tissue-specific migration of lymphocytes. Immunity 2002, 16:1-4.
95. Peel S. Experimental evidence for the bone marrow origin of granulated metrial gland cells of the mouse uterus. Cell Tissue Res. 1983, 233:647-656.
96. Male V., et al. Immature NK cells, capable of producing IL-22, are present in human uterine mucosa. J. Immunol. 2010, 185:3913-3918.
97. Lynch L., et al. Cells with haematopoietic stem cell phenotype in adult human endometrium: relevance to infertility?. Hum. Reprod. 2007, 22:919-926.
98. Guimond M.J., et al. Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient tg epsilon 26 mice. J. Exp. Med. 1998, 187:217-223.
99. Bilinski M.J., et al. Uterine NK cells in murine pregnancy. Reprod. Biomed. Online 2008, 16:218-226.
100. Freud A.G., Caligiuri M.A. Human natural killer cell development. Immunol. Rev. 2006, 214:56-72.
101. Sivori S., et al. Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:4526-4531.
102. + cells from human thymocyte precursors. J. Exp. Med. 1991, 174:21-26.
103. Marquez C., et al. Identification of a common developmental pathway for thymic natural killer cells and dendritic cells. Blood 1998, 91:2760-2771.
104. bright natural killer cells. Immunity 2005, 22:295-304.
105. Vacca P., et al. CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:2402-2407.
106. Giron-Michel J., et al. Membrane-bound and soluble IL-15/IL-15Ralpha complexes display differential signaling and functions on human hematopoietic progenitors. Blood 2005, 106:2302-2310.